JP Stock MarketDetailed Quotes
2160 GNI Group
- 2537
- +96+3.93%
20min DelayMarket Closed Jul 12 15:00 JST
126.85BMarket Cap15.32P/E (Static)
2554High2438Low848.70KVolume2441Open2441Pre Close2.14BTurnover386552wk High1.80%Turnover Ratio50.00MShares116652wk Low193.62EPS TTM119.47BFloat Cap4070Historical High15.32P/E (Static)47.09MShs Float13Historical Low165.56EPS LYR4.75%Amplitude--Dividend TTM3.66P/B100Lot Size--Div YieldTTM
About GNI Group Company
GNI Group Ltd is a clinical stage drug development company. It works on the treatment of diseases that are more common in Asia, especially Japan and China. It is engaged in the discovery, development, manufacture, and sale of drugs for the treatment of cancer and inflammatory diseases.
Company Profile
Symbol2160
Company NameGNI Group
Founded2001-11-20
MarketTSE Growth
Employees720
Fiscal Year Ends12-31
AddressShinjuku Park Tower 3-7-1 Nishi-Shinjuku
Zip Code103-0023
Phone03-6214-3600
Websitewww.gnipharma.com
Company Executives
- Name
- Position
- Salary
- Dr. Ying Luo, PhD
- Director, Representative Executive Officer, President and Chief Executive Officer
- --
- Toshiya Kitagawa
- Director, Executive Officer and Chief Financial Officer
- --
- Sekitani Kazuki
- Director, Executive Officer and Chief Operating Officer
- --
- Thomas Eastling
- Director
- --
- Ryosuke Matsui
- Director
- --
- Hideaki Sashiwa
- Independent Director
- --
- Kikuchi Kanako
- Independent Director
- --
- Zhang Ping
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
JP
Overall
Symbol
Latest Price
%Chg